Clinical Trial Update: IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia [Phase 3]

View source ↗

Summary

This notice indicates that a Phase 3 trial of IBI-306 monotherapy for non-familial hypercholesterolemia and mixed hyperlipidemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Non-familial Hypercholesterolemia

Drugs mentioned

• IBI-306

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Phase 3 | Status: RECRUITING